Abstract
A large body of scientific research accumulated over the past twenty years documents the cardiovascular (CV) benefits of estradiol (E2) and progesterone (P4) in reproductive-aged women. In contrast, accelerated development of CV disease (CVD) occurs in the absence of ovarian-produced...